These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33604775)
1. Pioglitazone Attenuates Lupus Nephritis Symptoms in Mice by Modulating miR-21-5p/TIMP3 Axis: the Key Role of the Activation of Peroxisome Proliferator-Activated Receptor-γ. Liu D; Zhang W Inflammation; 2021 Aug; 44(4):1416-1425. PubMed ID: 33604775 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of microRNA-182-5p contributes to attenuation of lupus nephritis via Foxo1 signaling. Wang X; Wang G; Zhang X; Dou Y; Dong Y; Liu D; Xiao J; Zhao Z Exp Cell Res; 2018 Dec; 373(1-2):91-98. PubMed ID: 30308195 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-181d-5p regulates the MAPK signaling pathway by targeting mitogen-activated protein kinase 8 (MAPK8) to improve lupus nephritis. Chai F; Peng H; Qin L; Liu C; Zeng Y; Wang R; Xu G; Wang R; Wei G; Huang H; Lan Y; Chen W; Wang C Gene; 2024 Jan; 893():147961. PubMed ID: 37931853 [TBL] [Abstract][Full Text] [Related]
4. CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling. Xu ZQ; Ding Y; Huang XY; Xiang W; He XJ Inflammation; 2021 Oct; 44(5):2106-2119. PubMed ID: 34091806 [TBL] [Abstract][Full Text] [Related]
5. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome. Su B; Ye H; You X; Ni H; Chen X; Li L Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016 [TBL] [Abstract][Full Text] [Related]
6. Rutin alleviates lupus nephritis by inhibiting T cell oxidative stress through PPARγ. Yi T; Zhang W; Hua Y; Xin X; Wu Z; Li Y; Wen C; Fan Y; Ji J; Xu L Chem Biol Interact; 2024 May; 394():110972. PubMed ID: 38555047 [TBL] [Abstract][Full Text] [Related]
7. miR‑146a‑5p protects against renal injury in MRL/lpr mice via improvement of the Treg/Th17 imbalance by targeting the TRAF6/NF‑κB axis. Teng J; Yang F; Li X Exp Ther Med; 2023 Jan; 25(1):21. PubMed ID: 38895650 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1. Qi H; Cao Q; Liu Q Exp Cell Res; 2020 Sep; 394(2):112138. PubMed ID: 32535034 [TBL] [Abstract][Full Text] [Related]
9. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247 [TBL] [Abstract][Full Text] [Related]
10. miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis. Liu D; Zhang N; Zhang J; Zhao H; Wang X Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):616-25. PubMed ID: 27028192 [TBL] [Abstract][Full Text] [Related]
11. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice. Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis. Cheng T; Ding S; Liu S; Li Y; Sun L Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511 [No Abstract] [Full Text] [Related]
13. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis. Kong J; Li L; Lu Z; Song J; Yan J; Yang J; Gu Z; Da Z Inflammation; 2019 Feb; 42(1):255-263. PubMed ID: 30209639 [TBL] [Abstract][Full Text] [Related]
14. CircRTN4 aggravates mesangial cell dysfunction by activating the miR-513a-5p/FN axis in lupus nephritis. Miao X; Tian Y; Wu L; Zhao H; Liu J; Gao F; Zhang W; Liu Q; Guo H; Yang L; Yang R; Feng X; Liu S Lab Invest; 2022 Sep; 102(9):966-978. PubMed ID: 35523949 [TBL] [Abstract][Full Text] [Related]
15. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats. Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822 [TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network. Cheng C; Guo F; Yang H; Ma J; Li H; Yin L; Li M; Liu S Lupus; 2022 Dec; 31(14):1786-1799. PubMed ID: 36223498 [TBL] [Abstract][Full Text] [Related]
17. PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity. Chen JY; Wu YP; Li CY; Jheng HF; Kao LZ; Yang CC; Leu SY; Lien IC; Weng WT; Tai HC; Chiou YW; Tang MJ; Tsai PJ; Tsai YS J Biomed Sci; 2021 Mar; 28(1):22. PubMed ID: 33781257 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus. Aprahamian TR; Bonegio RG; Weitzner Z; Gharakhanian R; Rifkin IR Immunology; 2014 Jul; 142(3):363-73. PubMed ID: 24456224 [TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice. Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling. Wang X; Cheng W; Chen X; Gong Y; Wang G; Zhang X; Qi Y Mediators Inflamm; 2022; 2022():2298865. PubMed ID: 36248187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]